InnoCare Pharma Limited

InnoCare Pharma Limitedverified

INCPF

Price:

$1.55

Market Cap:

$13.33B

InnoCare Pharma Limited is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments, primarily targeting cancer and autoimmune disorders. A key product in their portfolio is Orelabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor. This therapy targets various relapsed or refractory blood cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom's macroglobulinemia, marginal zone lymphoma, diffuse large B-cell lymphoma (MCD subtype), central nervous system lymphoma, and is also being explored in combination with MIL-62. Furthermore, Orelabrutinib is under investigation for a range of autoimmune conditions su...[Read more]

Industry

Biotechnology

IPO Date

2021-07-09

Stock Exchange

OTC

Ticker

INCPF

The Enterprise Value as of June 2026 (TTM) for InnoCare Pharma Limited (INCPF) is 8.97B

According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 8.97B. This represents a change of -44.34% compared to the average of 16.11B of the last 4 quarters.

InnoCare Pharma Limited (INCPF) Historical Enterprise Value (quarterly & annually)

How has INCPF Enterprise Value performed in the past?

The mean historical Enterprise Value of InnoCare Pharma Limited over the last ten years is 9.29B. The current 8.97B Enterprise Value has changed 9.55% with respect to the historical average. Over the past ten years (40 quarters), INCPF's Enterprise Value was at its highest in in the June 2021 quarter at 26.51B. The Enterprise Value was at its lowest in in the March 2024 quarter at -175886540.87.

Quarterly (TTM)
Annual

Average

9.29B

Median

9.93B

Minimum

3.78B

Maximum

14.00B

InnoCare Pharma Limited (INCPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InnoCare Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 193.73%

Maximum Annual Enterprise Value = 14.00B

Minimum Annual Increase = -63.60%

Minimum Annual Enterprise Value = 3.78B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202514.00B193.73%
20244.77B26.26%
20233.78B-63.60%
202210.37B-16.09%
202112.36B48.83%
20208.31B-15.34%
20199.81B-1.17%
20189.93B-3.78%

InnoCare Pharma Limited (INCPF) Average Enterprise Value

How has INCPF Enterprise Value performed in the past?

The current Enterprise Value of InnoCare Pharma Limited (INCPF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.52B

5-year avg

9.06B

10-year avg

9.29B

InnoCare Pharma Limited (INCPF) Enterprise Value vs. Peers

How is INCPF’s Enterprise Value compared to its peers?

InnoCare Pharma Limited’s Enterprise Value is less than Shanghai Junshi Biosciences Co., Ltd. (31.99B), greater than Genscript Biotech Corporation (3.23B), less than ALK-Abelló A/S (57.36B), greater than Laboratorios Farmaceuticos Rovi, S.A. (2.99B), less than Zealand Pharma A/S (15.97B), less than Camurus AB (publ) (27.12B), less than COSMOS Pharmaceutical Corporation (499.78B), greater than Fielmann AG (4.31B), less than Clicks Group Limited (58.30B), less than Gedeon Richter PLC (1.92T),

Build a custom stock screener for InnoCare Pharma Limited (INCPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoCare Pharma Limited (INCPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is InnoCare Pharma Limited's Enterprise Value?

What is the highest Enterprise Value for InnoCare Pharma Limited (INCPF)?

What is the 3-year average Enterprise Value for InnoCare Pharma Limited (INCPF)?

What is the 5-year average Enterprise Value for InnoCare Pharma Limited (INCPF)?

How does the current Enterprise Value for InnoCare Pharma Limited (INCPF) compare to its historical average?